| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |